18876211000001106: Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Fludarabine\Product containing only fludarabine in parenteral dose form (medicinal product form)\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Fludarabine\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing fludarabine\Fludarabine\Product containing only fludarabine in parenteral dose form (medicinal product form)\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing fludarabine\Fludarabine\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing fludarabine\Product containing fludarabine in parenteral dose form (medicinal product form)\Product containing only fludarabine in parenteral dose form (medicinal product form)\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing purine and/or purine derivative (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing fludarabine\Fludarabine\Product containing only fludarabine in parenteral dose form (medicinal product form)\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing purine and/or purine derivative (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing fludarabine\Fludarabine\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing purine and/or purine derivative (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing fludarabine\Product containing fludarabine in parenteral dose form (medicinal product form)\Product containing only fludarabine in parenteral dose form (medicinal product form)\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing fludarabine\Fludarabine\Product containing only fludarabine in parenteral dose form (medicinal product form)\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing fludarabine\Fludarabine\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing fludarabine\Product containing fludarabine in parenteral dose form (medicinal product form)\Product containing only fludarabine in parenteral dose form (medicinal product form)\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as parenteral dose form\Product containing fludarabine in parenteral dose form (medicinal product form)\Product containing only fludarabine in parenteral dose form (medicinal product form)\Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection\Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Jun 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

64276301000001117 Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

64276401000001113 Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	Is a	Product containing precisely fludarabine phosphate 50 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	Has active ingredient	Fludarabine	false	Inferred relationship	Existential restriction modifier
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	Has manufactured dose form	Powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	Has specific active ingredient	Fludarabine phosphate	true	Inferred relationship	Existential restriction modifier
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	Has dispensed dose form	Powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial	Has AMP	True	Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64276301000001117	Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
64276401000001113	Fludarabine phosphate 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module